Since Judge Amy Coney Barrett was nominated to serve on the Supreme Court, Joe Biden and Senate Democrats have repeatedly said that Barrett would be a vote to strike down the Affordable Care Act (ACA), which most of us know as Obamacare.

Welcome to the new and improved Regulatory Action Center (RAC) Review! RAC proudly keeps you up to date on what we’re up to and what we’re keeping our eyes on here in the swamp. We offer resources for you to get involved in the rulemaking process to hold unelected bureaucrats accountable and occasionally offer praise in the event they have a good impulse. We will also highlight the incredible work our activists have done to advance the principles of smaller government, lower taxes, free markets, personal liberty, and the rule of law. For more ways to get involved and stay informed, check the links at the bottom of this post.

FreedomWorks Foundation’s Regulatory Action Center (RAC) has launched a scorecard for the 16 nations to which the Department of Health and Human Services (HHS) wants to tie the United States when it comes to prescription drug prices. The scorecard shows what most in Washington should already know: price controls are a surefire prescription for failure.

FreedomWorks Foundation's Regulatory Action Center (RAC) submitted comments to the Centers for Medicare and Medicaid Services (CMS) regarding regulatory changes for outpatient facilities. This proposal would grant more flexibility to physicians and patients to seek care at lower costs. It also repeals regulations unnecessarily implemented by Obamacare.

If you used your free time on Saturday or Sunday to watch football, you may have seen an ad run by Joe Biden’s campaign in which the narrator says that Biden won’t raise taxes on anyone earning less than $400,000 annually. The ad perpetuates the myth that the Tax Cuts and Jobs Act was a “tax cut for the rich.” As Chris Edwards of the Cato Institute notes, the Tax Cuts and Jobs Act “provided the largest percentage tax cuts to the bottom two quintiles—that is, the bottom 40 percent of U.S. households.”

Welcome to the new and improved Regulatory Action Center (RAC) Review! RAC proudly keeps you up to date on what we’re up to and what we’re keeping our eyes on here in the swamp. We offer resources for you to get involved in the rulemaking process to hold unelected bureaucrats accountable and occasionally offer praise in the event they have a good impulse. We will also highlight the incredible work our activists have done to advance the principles of smaller government, lower taxes, free markets, personal liberty, and the rule of law. For more ways to get involved and stay informed, check the links at the bottom of this post.

Prices for prescription drugs in the U.S. are far too high. There is no denying this sad reality. According to an analysis done by the House Ways and Means Committee, the U.S. pays roughly four times as much as 11 similar nations for prescription drugs. For millions of patients, families, and caregivers, this is unacceptable. Policymakers are right when they say something needs to be done.